IgG4-related sclerosing cholangitis may be a risk factor for cancer.

Yusuke KuritaYuji FujitaYusuke SekinoSeitaro WatanabeAkito IwasakiKoichi KagawaEmiko TanidaShin YagiSho HasegawaTakamitsu SatoKunihiro HosonoShingo KatoNoritoshi KobayashiYasushi IchikawaItraru EndoAtsushi NakajimaKensuke Kubota

Published in: Journal of hepato-biliary-pancreatic sciences (2021)

IgG4-SC patients have a high risk of cancer including pancreatic and bile duct cancer. The risk of cancer was high less <1 year and >5 years after diagnosis of IgG4-SC. Therefore, IgG4-SC patients may require careful long-term follow-up.

Keyphrases

papillary thyroid
end stage renal disease
squamous cell
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
lymph node metastasis
patient reported outcomes
patient reported